SCHEMBL4189854

SCHEMBL4189854

C[C@@H](CC1CCCCC1)NCc1ccccc1NS(=O)(=O)c1ccc(-c2cccc(C(F)(F)F)c2)s1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PFKFB3 Q16875 1/20 0.41
MAPT P10636 2/20 0.38
RXFP1 Q9HBX9 2/20 0.37
PTGES2 Q9H7Z7 2/20 0.37
GHSR Q92847 2/20 0.36
KDM4E B2RXH2 1/20 0.35
PKM P14618 1/20 0.35
KMT2A Q03164 2/20 0.35
IDE P14735 1/20 0.35
PAX8 Q06710 1/20 0.35
MMP1 P03956 2/20 0.35
MMP13 P45452 2/20 0.35
CTSS P25774 2/20 0.34
MEN1 O00255 1/20 0.34
ELANE P08246 1/20 0.33
LMNA P02545 1/20 0.33
GAA P10253 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CTSL P07711 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4196692 1.00 PFKFB3 (0.41) PFKFB3MAPTRXFP1PTGES2GHSR
SCHEMBL4185970 0.91 KDM4E (0.40) PFKFB3MAPTRXFP1GHSRKDM4E
SCHEMBL4203709 0.90 GHSR (0.43) PFKFB3MAPTRXFP1PTGES2GHSR
SCHEMBL4197519 0.90 GHSR (0.43) PFKFB3MAPTRXFP1PTGES2GHSR
SCHEMBL4197564 0.90 KDM4E (0.39) PFKFB3MAPTRXFP1GHSRKDM4E
SCHEMBL4194037 0.89 GHSR (0.44) PFKFB3MAPTRXFP1PTGES2GHSR
SCHEMBL4198366 0.87 KDM4E (0.35) RXFP1GHSRKDM4EPKMKMT2A
SCHEMBL4198289 0.87 GHSR (0.38) MAPTPTGES2GHSRKDM4EPKM
SCHEMBL4195119 0.87 GHSR (0.38) MAPTPTGES2GHSRKDM4EPKM
SCHEMBL4204407 0.87 KDM4E (0.35) RXFP1PTGES2GHSRKDM4EPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP claimed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US claimed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US claimed
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP disclosed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US disclosed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215764-A1 Antimicrobial agents TUFM, RPS17, HARS1 PFKFB3 2039/4885MAPT 2269/4885RXFP1 4881/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.